A comparative study of phytoestrogen action in mitigating apoptosis induced by oxidative stress

In Vivo

Volumn 26, Issue 5, 2012, Pages 765-775

  Ondricek, Amber J ^a   Kashyap, Abhishek K ^b   Thamake, Sanjay I ^a   Vishwanatha, Jamboor K ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antioxidants; Glaucoma; Neurodegenerative disease; Neuroprotection; Oxidative stress; Phytoestrogens; RGC 5 cells

Indexed keywords

APIGENIN; CASPASE; FISETIN HYDRATE; GENISTEIN; GENISTIN; IODOACETIC ACID; KAEMPFEROL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHYTOESTROGEN; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; S6 KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; IN VITRO STUDY; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION;

EID: 84866630010     PISSN: 0258851X     EISSN: 17917549     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Beal MF: Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol 6: 661-666, 1996.
2. Kumar DM and Agarwal N: Oxidative stress in glaucoma: a burden of evidence. J. Glaucoma 16: 334-343, 2007.
3. Trachootham D, Lu W, Ogasawara MA, Nilsa RD and Huang P: Redox regulation of cell survival. Antioxid Redox Signal 10: 1343-1374, 2008.
4. Mainster MA: Light and macular degeneration: a biophysical and clinical perspective. Eye 1(Pt 2): 304-310, 1987. (Pubitemid 17126434)
5. Organisciak DT, Darrow RM, Barsalou L, Darrow RA, Kutty RK, Kutty G and Wiggert B: Light history and age-related changes in retinal light damage. Invest Ophthalmol Vis Sci 39: 1107-1116, 1998. (Pubitemid 28247344)
6. Flammer J: The vascular concept of glaucoma. Surv Ophthalmol 38 Suppl: S3-6, 1994.
7. Quigley HA:Neuronal death in glaucoma. Prog Retin Eye Res 18: 39-57, 1999.
8. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634, 1988.
9. Ritch R: Neuroprotection: is it already applicable to glaucoma therapy? Curr Opin Ophthalmol 11: 78-84, 2000.
10. Yoles E, Wheeler LA and Schwartz M: Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest. Ophthalmol. Vis Sci 40: 65-73, 1999. (Pubitemid 29029573)
11. Osborne NN: In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent. Brain Res 751: 113-123, 1997.
12. Manthey D and Behl C: From structural biochemistry to expression profiling: neuroprotective activities of estrogen. Neuroscience 138: 845-850, 2006.
13. Chen H, Liu B and Neufeld AH: Epidermal growth factor receptor in adult retinal neurons of rat, mouse, and human. J Comp Neurol 500: 299-310, 2007. (Pubitemid 44937124)
14. Dibas A, Yang MH, Bobich J and Yorio T: Stress-induced changes in neuronal Aquaporin-9 (AQP9) in a retinal ganglion cell-line. Pharmacol Res 55: 378-384, 2007. (Pubitemid 46560389)
15. Dun Y, Mysona B, Van Ells T, Amarnath L, Ola MS, Ganapathy V and Smith SB: Expression of the cystine-glutamate exchanger (xc-) in retinal ganglion cells and regulation by nitric oxide and oxidative stress. Cell Tissue Res 324: 189-202, 2006.
16. Ju WK, Misaka T, Kushnareva Y, Nakagomi S, Agarwal N, Kubo Y, Lipton SA and Bossy-Wetzel E: OPA1 expression in the normal rat retina and optic nerve. J Comp Neurol 488: 1-10, 2005. (Pubitemid 40770825)
17. Krishnamoorthy RR, Agarwal P, Prasanna G, Vopat K, Lambert W, Sheedlo HJ, Pang IH, Shade D, Wordinger RJ, Yorio T, Clark AF and Agarwal N: Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res 86: 1-12, 2001. (Pubitemid 32124753)
18. Chalasani ML, Radha V, Gupta V, Agarwal N, Balasubramanian D and Swarup G: A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants. Invest Ophthalmol Vis Sci 48: 1607-1614, 2007.
19. Khalyfa A, Chlon T, Qiang H, Agarwal N and Cooper NG: Microarray reveals complement components are regulated in the serum-deprived rat retinal ganglion cell line. Mol Vis 13: 293-308, 2007.
20. Van Bergen NJ, Wood JP, Chidlow G, Trounce IA, Casson RJ, Ju WK, Weinreb RN and Crowston,JG: Recharacterization of the RGC-5 retinal ganglion cell line. Invest Ophthalmol Vis Sci 50: 4267-4272, 2009.
21. Winkler BS, Sauer MW and Starnes CA: Modulation of the Pasteur effect in retinal cells: implications for understanding compensatory metabolic mechanisms. Exp Eye Res 76: 715-723, 2003. (Pubitemid 36553089)
22. Noell WK: The effect of iodoacetate on the vertebrate retina. J Cell Physiol 37: 283-307, 1951.
23. Malcolm CS, Benwell KR, Lamb H, Bebbington D and Porter RH: Characterization of iodoacetate-mediated neurotoxicity in vitro using primary cultures of rat cerebellar granule cells. Free Radic Biol Med 28: 102-107, 2000. (Pubitemid 30045578)
24. Sperling O, Bromberg Y, Oelsner H and Zoref-Shani E: Reactive oxygen species play an important role in iodoacetate-induced neurotoxicity in primary rat neuronal cultures and in differentiated PC12 cells. Neurosci Lett 351: 137-140, 2003. (Pubitemid 37410323)
25. Ferreira IL, Duarte CB and Carvalho AP: 'Chemical ischemia' in cultured retina cells: the role of excitatory amino acid receptors and of energy levels on cell death. Brain Res 768: 157-166, 1997. (Pubitemid 27433488)
26. Taylor BM, Fleming WE, Benjamin CW, Wu Y, Mathews WR and Sun FF: The mechanism of cytoprotective action of lazaroids I: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion. J. Pharmacol Exp Ther 276: 1224-1231, 1996.
27. Reiner PB, Laycock AG and Doll CJ: A pharmacological model of ischemia in the hippocampal slice. Neurosci Lett 119: 175-178, 1990. (Pubitemid 20379250)
28. Windisch M, Hutter-Paier B, Grygar E, Doppler E and Moessler H: N-PEP-12 - a novel peptide compound that protects cortical neurons in culture against different age and disease associated lesions. J Neural Transm 112: 1331-1343, 2005. (Pubitemid 41355961)
29. Valsecchi AE, Franchi S, Panerai AE, Sacerdote P, Trovato AE and Colleoni M: Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: anti-inflammatory and antioxidant activity. J Neurochem 107: 230-240, 2008.
30. Sawada H and Shimohama S: Estrogens and Parkinson disease: novel approach for neuroprotection. Endocrine 21: 77-79, 2003. (Pubitemid 36677346)
31. Kajta M, Domin H, Grynkiewicz G and Lason W: Genistein inhibits glutamate-induced apoptotic processes in primary neuronal cell cultures: an involvement of aryl hydrocarbon receptor and estrogen receptor/glycogen synthase kinase-3beta intracellular signaling pathway. Neuroscience 145: 592-604, 2007. (Pubitemid 46341646)
32. Owusu-Ansah E, Yavari A, Mandal S and Banerjee U: Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint. Nat Genet 40: 356-361, 2008. (Pubitemid 351311760)
33. Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ and Bickford PC: Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19: 8114-8121, 1999. (Pubitemid 30225807)
34. Dinkova-Kostova AT, Cheah J, Samouilov A, Zweier JL, Bozak RE, Hicks RJ and Talalay P: Phenolic Michael reaction acceptors: combined direct and indirect antioxidant defenses against electrophiles and oxidants. Med Chem 3: 261-268, 2007. (Pubitemid 46773942)
35. Mitchell JH, Gardner PT, McPhail DB, Morrice PC, Collins AR and Duthie GG: Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys 360: 142-148, 1998. (Pubitemid 29010923)
36. Xu YM, Smith JA, Lannigan DA and Hecht SM: Three acetylated flavonol glycosides from Forsteronia refracta that specifically inhibit p90 RSK. Bioorg Med Chem 14: 3974-3977, 2006.